Metraipolis › archive › dc_91c2f3da8762

Dapagliflozin Augmentation of Sacubitril/Valsartan Therapy in Patients With Heart Failure Following PCI-Treated Acute Myocardial Infarction: A Meta-Analysis… — Europe PMC PMID:42491272

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42491272
DOI
10.1155/crp/1274068
License (as archived)
solo-consultazione
Archived
2026-10-18T06:14:41.397Z
SHA-256 of the archived text
59c988f2d7691f66c344b36ac574825674596f52d473d8c042afbb06a680a199
Stable URL of this page
https://metraipolis.com/documento/dc_91c2f3da8762

How to cite

Dapagliflozin Augmentation of Sacubitril/Valsartan Therapy in Patients With Heart Failure Following PCI-Treated Acute Myocardial Infarction: A Meta-Analysis… — Europe PMC PMID:42491272 — Europe PMC (en), https://europepmc.org/article/MED/42491272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_91c2f3da8762 (Metraipolis archive dc_91c2f3da8762, sha256 59c988f2d7691f66c344b36ac574825674596f52d473d8c042afbb06a680a199)
BibTeX
@misc{dc91c2f3da8762,
  title = {Dapagliflozin Augmentation of Sacubitril/Valsartan Therapy in Patients With Heart Failure Following PCI-Treated Acute Myocardial Infarction: A Meta-Analysis… — Europe PMC PMID:42491272},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42491272},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_91c2f3da8762; sha256 59c988f2d7691f66c344b36ac574825674596f52d473d8c042afbb06a680a199},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42491272. Agents can read the archived copy with the MCP tool read_document.